Introduction
In assisted reproductive technology (ART), pregnancy and birth rates following IVF attempts remain low. Indeed, 2 out of 3 IVF cycles fail to result in pregnancy and more than 8 out of 10 transferred embryos fail to implant ( ). Indeed, Kovalevsky and Patrizio, 2005 successful implantation requires a competent embryo, a receptive endometrium and a synchronized dialogue between maternal and embryonic tissues. Although the selection of competent oocyte, embryo and endometrial status assessment has experienced important technological progress, implantation rates are still low under COS for IVF ( ). It is assumed that two-thirds of Donaghay and Lessey, 2007 implantation failures are associated with inadequate endometrial receptivity or with defects in the embryo-endometrium dialogue (Paulson ; ). ., 1990 et al Simon ., 1998 et al Several parameters have been suggested for assessing endometrial receptivity, including endometrial thickness which is a traditional criterion, endometrial morphological aspect, and endometrial and sub-endometrial blood flow. However, their positive predictive value is still limited ( ; ; ). More recently, transcriptomic approaches have been driven to identify Friedler ., 1996 et al Pierson, 2003 Alc zar, 2006 á bio-markers of the endometrial receptivity. Using microarray technology in human endometrial biopsy samples, several studies have reported modifications related to the gene expression profile associated with the transition of the human endometrium from a pre-receptive (early-secretory phase) to a receptive (mid-secretory phase) state during a natural cycle ( ; ; Carson al., 2002 et Riesewijk ., 2003 ; ) . However, recent data suggested that COS regimens may have a negative The divergence between the reports analyzing the effects of stimulation protocols on endometrial receptivity may have several explanations: differences in the day of the endometrial biopsies, different patient profiles, different COS protocols, and inadequate numbers of endometrial samples studied. In addition, no study has compared the early and the mid-secretory phases during a natural and stimulated cycle for the same patients, which seems an essential condition to minimize the impact of inter-patient variability.
The aim of this study was to evaluate the global gene expression profile of human endometrial biopsies of normal responder patients during the early-secretory phase and the mid-secretory phase of natural and stimulated cycles in the same patients.
Materials and methods

Patient characteristics and endometrial biopsies
The study population included 21 normal responders patients (age 30.9 years 3.3) referred for ICSI for male infertility factor ± recruited after written informed consent. All patients had normal serum FSH, LH and estradiol on day 3 and were normal-responders during a previous first ICSI attempt. This project has received institutional review board (IRB) approval. During the same natural cycle that preceded a second ICSI attempt, two endometrial biopsies were obtained in all women at day 2 (LH 2) and day 7 (LH 7) after the LH + + peak and two others were obtained at day 2 (hCG 2) and day 5 (hCG 5) after hCG administration during COS cycles. The LH surge was
estimated by the patient herself according to the first day of her menstruation. Histologic analysis was not performed to verify that the LH timing was accurate. Therefore, the possibility for a delay of one day from the first day of the menstruation cannot be excluded. Each biopsy sample was frozen at 80 C in RLT RNA extraction buffer (RNeasy kit, Qiagen, Valencia, CA, USA).
−°C
omplementary RNA (cRNA) preparation and microarray hybridization
Endometrial samples RNA were extracted using the micro RNeasy Kit (Qiagen). The total RNA quantity was measured with a Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies Inc., DE, USA) and RNA integrity was assessed with an Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA, USA). cRNA was prepared with two rounds of amplification according to the manufacturer s ' protocol double amplification (Two-Cycle cDNA Synthesis Kit, Invitrogen) starting from total RNA (100 ng). Labeled fragmented " " cRNA (12 g) was hybridized to oligonucleotide probes on Affymetrix HG-U133 Plus 2.0 arrays containing 54 675 sets of oligonucleotide μ probes ( probe set ) which correspond to 30 000 unique human genes or predicted genes. Each endometrial sample was put individually " " ≈ on a microarray chip.
Data processing
Scanned GeneChip images were processed using Affymetrix GCOS 1.4 software to obtain an intensity value signal and a detection call (present, marginal or absent) for each probe set, using the default analysis settings and global scaling as the first normalization method, with a trimmed mean target intensity value (TGT) of each array arbitrarily set to 100. Probe intensities were derived using the MAS5.0 algorithm. This algorithm also determines whether a gene is expressed with a defined confidence level or not ( detection call ).
" "
This call can either be present (when the perfect match probes are significantly more hybridized than the mismatch probes, FDR <
0.04), marginal (for FDR > 0.04 and <0.06) or absent (FDR > 0.06). The microarray data were obtained in our laboratory in agreement
with the Minimal Information about Microarray Experiment MIAME recommendations.
Microarray data analysis
The Significant Analysis of microarrays (SAM, Stanford University, USA, ) was used to identify genes whose Tusher . 2001 et al expression varied significantly between the LH 2 (n 21) and LH 7 (n 21) samples and between the hCG 2 (n 21) and hCG 5 (n 21)
samples. SAM provides mean or median fold change values (FC) and a false discovery rate (FDR) confidence percentage based on data permutation. To perform the comparison of gene expression profiles between endometrial sample groups, a probe set selection using the Absent/Present detection call and a coefficient of variation (CV) ( 40 ) between samples was first performed before the SAM.
To compare profile expressions of endometrial samples (n 84) from the LH 2, LH 7, hCG 2 and hCG 5 sample groups, we 
Ingenuity Pathway Analysis
Selected gene lists were analyzed using Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, Redwood City, CA). Those genes with known gene symbols and their corresponding expression values were uploaded into the software. Each gene symbol was mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base. Networks of these genes were algorithmically generated based on their connectivity and assigned a score. The score is a numerical value used to rank networks according to how relevant they are to the genes in the input dataset but may not be an indication of the quality or significance of the network. The score takes into account the number of focus genes in the network and the size of the network to approximate how relevant this network is to the original list of focus genes. The network identified is then presented as a graph indicating the molecular relationships between genes/gene products. Genes are represented as nodes, and the biological relationship between two nodes is represented as an edge (line).
Results
Gene expression profile of endometrial receptivity during natural and stimulated cycles for the same patients
We selected 18,389 probe sets based on a CV 40 and a detection call present in at least 10 samples per group, and then subjected
the 84 samples to an unsupervised clustering ( ). A first branch allowed the separation of the pre-receptive (LH 2 and hCG 2) Figure 1A + + from the receptive sample groups (LH 7 and hCG 5), corresponding to 62, 57, 81 and 100 of the samples for LH 2, hCG 2, LH 7 and
hCG 5 respectively. A sub-branch allowed to partition the receptive samples between the natural (LH 7) and stimulated (hCG 5) cycles.
A three dimensional PCA was performed (4,237 probe sets), representing 43 of the data information, and confirmed the unsupervised % cluster analysis ( ). Figure 1B A SAM analysis between the LH 2 and the LH 7 and between the hCG 2 and the hCG 5 sample groups (LH 2 LH 7; hCG Table I genes allowed the separation of the two endometrial sample groups of the stimulated cycle ( ). Interestingly, more Figure 2B down-regulated genes were observed during endometrial receptivity of the stimulated cycle in comparison with the natural cycle.
A SAM analysis between the LH 2 and hCG 2 and between the LH 7 and hCG 5 sample groups (LH 2 hCG 2, LH 7
hCG 5, paired sample analysis) was performed. The number of significantly modulated genes is reported in . In contrast with other +   Table I studies, the comparison of gene expression profile between natural and stimulated cycles was performed by paired samples (hCG 2 versus + their corresponding LH 2), which is an important point to minimize inter-patient variability. For example, the number of genes + significantly modulated between LH 2 and hCG 2 samples analysed by paired or unpaired was dramatically different, highlighting the + + need to perform paired analyses and explaining differences with other studies.
Atypical gene expression profile in endometrium under stimulated cycles
The hierarchical clustering based on the stimulated cycle endometrium signature ( ) revealed that 14 (3/21 patients) of the Figure 2B % hCG 5 samples were misclassified. Interestingly, the same samples also displayed an altered expression profile at day hCG 2 ( + + Figure 3 and ). Hence, gene expression analysis of the endometrium transcriptome after COS can distinguish a standard profile shared by most 2B
" "
patients, and an atypical profile found in 14 of patients. A SAM analysis performed between the hCG 2 and hCG 5 samples reveals
that only one gene, TSPAN3 (x39.3, FDR<0.0001) was significantly modulated between these two sample groups in these three atypical " " patients compared to 1296 genes which were modulated in the 18 standard patients. This gene was not modulated during the transition
from the pre-receptive to the receptive stages in natural nor in the 18 standard patients of the stimulated cycles. We also performed a " "
SAM analysis between the hCG 2 of the 18 standard and the 3 atypical samples. 197 genes were significantly modulated, including 188
up-and 9 down-regulated genes, suggesting a strong difference in gene expression at hCG 2 between standard and atypical samples.
Among these genes, 24 up-and 2 down-regulated genes were specifically restricted to the hCG 2 atypical profile. In addition, the SAM
analysis between the standard hCG 5 sample group and the atypical hCG 5 sample group revealed that 14 genes were significantly
modulated, among which, 4 up-and 1 down-regulated genes were restricted to the atypical samples.
Differential expression of biological functions between natural and stimulated cycles
The two gene lists identified with SAM analyses between the pre-receptive and receptive samples from the natural and stimulated cycles were then intersected to determine their overlap. While 361 up-and 32 down-regulated genes were in common to the natural and stimulated cycles, each category displayed a specific gene expression profile ( ). These specific profiles included 632 up-and 46 Figure 4 down-regulated genes during the natural cycle, 416 up-and 189 down-regulated genes during the stimulated cycle. Interestingly, during the endometrial receptivity of the stimulated cycles, numerous genes which were down-regulated compared to natural cycles, were articulated around the cell cycle function ( ). Among this function, the most representative genes were those coding for Cyclins, Figure 5 Cell Division Cycle (CDC) members, Cyclin Dependent Kinases (CDK), and members of the E2F family of transcription factors. They included: CCNA2 (x-2.7, FDR<0.0001), CCNB1 (x-2.3, FDR<0.0001), and CCNE2 (x-2.1, FDR<0.0001), CDCA8 (x-2.8, FDR<0.0001), CDC25C (x-3.3, FDR<0.0001), CDCA5 (x-2.7, FDR<0.0001), CDC20 (x-2.8, FDR<0.0001), CDCA7 (x-2, FDR<0.0001), CDKN3 (x-2.9, FDR<0.0001), E2F1 (x-2.1, FDR<0.0001), E2F7 (x-2.9, FDR<0.0001), E2F8 (x-3.2, FDR<0.0001), as well as FOXM1 (x-2.1, FDR<0.0001), MYBL2 (x-2.8, FDR<0.0001), TK1 (x-2.2, FDR<0.0001), PBK (x-3.2, FDR<0.0001), CHAF1B (x-2.2, FDR<0.0001), BUB1 (x-2.7, FDR<0.0001), AURKA (x-2.2, FDR<0.0001), CHEK1 (x-2, FDR<0.0001), HDAC (x-3.5, FDR<0.0001), DHFR (x-2, FDR<0.0001) and CDT1 (x-2.5, FDR<0.0001) (
). Figure 5 
KEGG pathways between natural and stimulated cycles
We performed a FatiGO analysis with the two lists of up-regulated genes during endometrial receptivity of the natural and stimulated + cycles. There were numerous differences, between the natural and stimulated cycles, in main systems involved in the implantation process, such as the TGF signaling pathway, the complement and coagulation cascades, and leukocyte transendothelial migration ( ). during endometrial receptivity of the stimulated cycle ( ). Figure 6C 
Biomarkers of the endometrial receptivity during stimulated cycles
We also performed a PCA analysis of the hCG 2 and hCG 5 samples with the predictor list of endometrial receptivity as previously
The majority of the hCG 2 samples were separated from the hCG 5 samples, except for the three Haouzi ., 2009 et al
atypical samples, in this PCA using the first two dimensions representing 39 of the data information ( ). During the " % Figure 7 pre-receptive to the receptive transition in stimulated cycles, four of our biomarkers of endometrial receptivity were significantly up-regulated. For natural cycles compared to stimulated cycles, NLF2 was increased by a factor 12.6 compared to 2, PROK1 was increased by a factor of 10.2 compared to 7.8, MFAP5 was increased by a factor of 37 compared to 11.5, and LAMB3 was increased by a factor of 20.4 compared to 11.1. The upregulation observed in the microarray analyses was validated by QRT-PCR ( ; Haouzi ., 2009 et al ). Supplementary Figure 1 
ICSI outcome and biomarker genes
Seven ongoing pregnancies were obtained in the patients participating in this study. There were no significantly differences in the modulated genes between the pregnant and non pregnant patients either in the hCG 2 or hCG 5 subgroups.
+ +
Discussion
This is the first study analyzing by paired samples the endometrial gene expression profiles from the same patients during the pre-receptive to the receptive transition both in a natural and in a subsequent stimulated cycle. Although endometrium transition profiles are similar between patients, COS regimens affect endometrial receptivity in comparison with natural cycles. Two endometrium genes profiles were observed and associated either with a moderately altered receptivity for the majority of the patients or a strongly altered receptivity under COS conditions.
Differential gene expression profiles of endometrial receptivity between natural and stimulated cycles 5 11
In natural as well as stimulated cycles, the majority of the genes modulated during endometrial receptivity were up-regulated (93 in % the natural cycle compared to 78 in the stimulated cycle), suggesting that the receptive endometrium requires transcriptional activation involved in these signaling pathways was found in natural cycles, but was lacking in stimulated cycles. On the other hand, the expression profile of the receptive endometrium in stimulated cycles during COS showed more down-regulated genes than in the natural cycle (7 in natural compared to 22 in stimulated cycles respectively), suggesting that COS treatment, partly, induced gene repression.
% %
The majority of these down-regulated genes was not observed in the natural cycle (2 in common) and were related to the cell cycle
function, suggesting a negative impact of gonadotropins treatment during COS on this function. Several cyclins (cyclin A2, B1 and E2), cell-division cycles (CDCA5, A8, A7, 20 and 25C), and members of E2F family (E2F1, 7 and 8), which are key regulators of cell cycle, as well as numerous genes articulated around them, were not upregulated in stimulated cycles. Moreover, genes involved in checkpoint regulation, which are molecular circuits monitoring DNA integrity and cell growth prior to replication and division at the G1/S and G2/M transitions respectively, were also not upregulated in stimulated cycles ( the study design (LH 7/9 compared to hCG 7/9 in the Horcajadas s study, LH 2 and LH 7 compared to hCG 2 and hCG 5 in the present
study), the size of patient samples (n 5 per group in the Horcajadas s study, n 21 per group in the present study) as well as the samples, = ' = which were obtained from different fertile patients candidates for oocytes donation in the Horcajadas s study, could contribute to these ' diverging results ( ). By contrast, in the present study the comparison of gene expression profiles between natural Horcajadas ., 2008 et al and stimulated cycles was performed in the same normal-responder patients, which is an important point to minimize inter-patient variability.
We can wonder about the impact of multiple biopsies performed on the same patient.
reported that the first Kalma al. (2008) et endometrial biopsy modulated a wide variety of genes in the same cycle as well as in the following cycle, which can consequently mask true gene expression profile differences. However, all patients were subjected similarly to four biopsies. If biopsies affect all samples equally, so this should not prevent the identification of different gene expression profiles. Therefore, gene expression profile differences observed during the pre-receptive to the receptive endometrial transition under COS regimens (hCG 2 compared to hCG 5) between the + + two described endometrial profiles (endometrial receptivity moderately and strongly altered) suggested, contrariwise, that true differences are not masked. In addition, although showed that multiple endometrium biopsies during the spontaneous menstrual Barash
. (2003) However, in this cohort, pregnancy rate (7/21 patients) was similar to those habitually acquired, suggesting a no detrimental effect on implantation process.
Atypical gene expression profile of endometrial cells during COS
The comparisons of gene expression from the same patients between natural and stimulated cycles revealed endometrial profiles associated either with a moderately altered receptivity in most cases (86 ) or a strongly altered receptivity during the COS protocol in a % few cases (14 ) . In these few cases, the transition from the oocyte collection day (hCG 2) to the embryo transfer day (hCG 5) phase was already apparent at hCG 2 in these samples as judged by the gene number significantly modulated (197 genes) between these samples + and those associated with a moderately altered receptivity. However, on hCG 5, there were fewer differences between the two endometrial + profiles.
We previously described a predictor list (comprising 60 probe sets) of endometrial receptivity during natural cycle (Haouzi ., et al ). These predictors confirmed the presence of the two endometrial profiles: either receptive or not receptive. However, among these 2009 predictors, only four were significantly up-regulated during the pre-receptive to the receptive transition in the stimulated cycle. In addition, the fold changes between the pre-receptive to the receptive phases in endometrial profiles associated with a positive receptive status were less pronounced in stimulated than in natural cycles, suggesting incomplete receptivity during COS. Therefore, our predictors further suggest the moderately altered receptivity status for the majority of the samples, as well as the strongly altered receptivity status for a few patients. When the receptiveness of the endometrium is seriously compromised during COS, fresh embryo replacement could be reconsidered. In these cases, embryos freezing enable the IVF attempt to be saved and the embryo transfer can be done later during a natural cycle. For these patients, the endometrial receptivity gene expression signature is of high value ( ). Haouzi , 2009 et al.
In conclusion, the transcriptomic pattern of endometrial cells in natural and stimulated cycles in the same patients reveals either moderate or strong alterations of endometrial receptivity under COS protocols. This information could open new perspectives, particularly in patients with multiple implantation failures. In this case, analysis of the endometrial profile could reveal a strongly altered profile during COS protocols, prompting the clinician to either adapt the IVF stimulation protocol or to perform embryo transfer later during a natural cycle.
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Alc zar (A) The majority of the genes specifically modulated during endometrial receptivity in stimulated cycles (998 genes) were up-regulated (777 up-regulated genes, 221 down-regulated genes). Red, up-regulated genes; green, down-regulated genes. (B) A hierarchical clustering was performed with this gene list, allowing the separation of the two sample groups. Rhomb black outline: Atypical samples.
Figure 3
The two endometrium profiles during the pre-receptive and the receptive stages in stimulated cycles The majority of patients (18/21 patients) were characterized by a common profile, called standard profile . Other patients (3/21) presented an " " atypical profile . PR, pre-receptive; R, receptive; red, up-regulated genes; green, down-regulated genes.
Figure 4
Venn diagram of transcripts up-regulated and down regulated during endometrial receptivity in the natural cycle compared to the stimulated cycle Each list of genes was determined with the SAM software with a FDR < 5 and a fold change > 2.
%
Figure 5
Down-regulated genes related to the cell cycle function in the receptive endometrium of stimulated cycles Genes involved in (A) the cell cycle, (B) G1/S checkpoint regulation, and (C) the G2/M DNA damage checkpoint. All of these genes were down-regulated in stimulated cycles in comparison with natural cycles. Green: down-regulated genes.
Figure 6
Major differences in main systems involved in implantation between natural and stimulated cycles To identify differential distributions of KEGG pathways, we performed a FatiGO analysis with the two lists of genes up-regulated gene + during endometrial receptivity of the natural and stimulated cycles. There were numerous differences, between the natural and stimulated cycles, in main systems involved in the implantation process, such as the TGF signaling pathway, the complement and coagulation cascades, β and leukocyte transendothelial migration. Red, genes up-regulated in natural cycles; pink, genes up-regulated in stimulated cycles. Table I Number of genes significantly modulated in 6 microarray analyses comparing the pre-receptive or receptive stages between natural and stimulated cycles. 657 0 This table compares our gene lists significantly modulated between LH 2 and hCG 2, and between LH 7 and hCG 5 with five other studies using the same approach. Atg, antagonist; Ag, agonist.
Study
+ + + +
